16 Sep 2011
In the US when the vaccine was first recommended for adolescents in 2005, the expectation was that protection would last for 10 years; however, currently available data suggest it wanes in most adolescents within 5 years. Based on that information, a single dose at the recommended age of 11 or 12 years may not offer protection through the adolescent years at which risk for meningococcal infection is highest (16 though 21 years of age). A booster dose is now recommended at age 16.
- Meningococcal Polysaccharide Vaccine Information for Consumers
- Meningococcal Polysaccharide Vaccine Information for Healthcare Professionals (includes dosage details)
- Side Effects of Meningococcal Polysaccharide Vaccine (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
... having any fever but blood tests showed high infection . later csf samples confirmed decease i m worried abt consequences pls guide me , her ...
2 answers • 9 Feb 2012
0 answers • 9 Nov 2013
... developed red serus weeping wounds on truck and then peripheral area of arms and legs. could this be due to the vaccine. they dry up and weeks ...
1 answer • 9 Nov 2014
I got my vaccine on a Friday, felt headachy and rundown all weekend. By Tuesday I was getting an outbreak. I hadn't had one in a pretty long ...
3 answers • 13 Nov 2014
MR VACCINE,PCV13 VACCINE,HIB VACCINE,DTAPVACCINE,INFLUENZA VACCINE,HEP A VAccinE AND also varicella vaccine n he is 2yrs old n he can barely move his ...
1 answer • 10 Feb 2015